Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Metagenomic next-generation sequencing of plasma cell-free DNA improves the early diagnosis of suspected infections

Fig. 3

Pathogen profiles presented by mNGS based on the final clinical diagnosis and the application of mNGS in assisting clinical care. (A) Distribution of potential pathogens identified by mNGS in blood samples. (B) The pathogens profiles presented by plasma cfDNA mNGS based on the final diagnosis. The number presented in the box was presented as the ratio of the case number of the pathogen relative to the total number of detected pathogens per patient in bacterial, fungal, viral or mixed infections. (C) The relationship between average hospitalized days and sampling time

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us